MarinaBayRXMarinaBayRX

Afinitor
Afinitor

34
A clinical formulation indicated for oncology support. This option utilizes inhibitory pathways to manage cellular proliferation and stabilize complex disease states.
Ingredient
Everolimus
Category
Oncology Support
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Everolimus
Reference Brand
Everolimus
Product Origin
Generic Alternative
Reference Manufacturer
Novartis
Product Form
Tablet, Dispersible Tablet
Regulatory Classification
Rx
Primary Category
Cancer Treatment
Product Category
mTOR Inhibitor
Pharmacological Class
mTOR Inhibitor
Manufacturer Description
Developed to manage tumor cell growth and address specific genetic syndromes to support disease control and mitigate the progression of advanced cancers effectively.
Mechanism of Action
Everolimus blocks the mTOR protein, a central controller of cell growth and blood vessel formation. By inhibiting this pathway, it stops cancer cells from multiplying and starves tumors of the blood supply they need.
Route of Administration
Oral
Onset Time
Steady state in 1–2 weeks
Duration
24 hours
Contraindications
Severe hypersensitivity to everolimus or sirolimus, Live vaccinations during treatment
Severe Adverse Events
Non-infectious pneumonitis (Lung inflammation), Severe infections, Kidney failure, Hemorrhage, Slow wound healing
Common Side Effects
Mouth sores, Fatigue
Uncommon Side Effects
Rash, Diarrhea, Nausea, Loss of appetite, Weight loss, Cough, Increased cholesterol
Drug Interactions
Ketoconazole, Ritonavir, Clarithromycin, Rifampin, St. John's Wort, Grapefruit juice
Pregnancy Safety Warnings
Contraindicated; can cause severe fetal harm.
Age Restrictions
Approved for pediatric patients for specific tuberous sclerosis indications.
Storage Guidelines
Store at room temperature protected from light and moisture.
Related Products
Temsirolimus, Sirolimus
Information for Afinitor is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories